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The first goal of this study was to evaluate the roles of different intracellular
proteolytic systems in accelerated skeletal muscle protein degradation. Total,
myofibrillar and non-myofibrillar proteolysis were determined in cultured L8/CID
muscle cells. Calpain proteolysis was assessed by over-expressed calpastatin inhibitory
domain (CD). Lysosomal proteolysis was determined in the presence of methylamine.
Ub-proteasome proteolysis was measured by inhibiting proteasome activity with Z-Leu-
Leu-Leu-H (aldehyde) (ZLLL). Accelerated protein degradation, induced by serum
withdrawal, increased myofibrillar and non-myofibrillar protein degradation by 31 and
38%, respectively. Inhibition of all protease systems reduced total protein degradation
by approximately 67%. Ub-proteasome and lysosomal pathways accounted for most
protein degradation (62% and 40%, respectively). The lysosome contributed non-
selectively to the myofibrillar protein (27%) and non-myofibrillar protein (27%)
turnover. The Ub-proteasome system appears mainly responsible for the myofibrillar
Redacted for Privacypooi degradation (10%) and has a slight effect in non-myofibrillar protein degradation
(5%). The calpain system has a slight effect on overall proteolysis (20%). However, the
calpain plays an important role in initiating muscle protein degradation.
Inhibition of the lysosomal and proteasome pathways stabilized tropomyosin,
desmin, filamin, a-actinin, and dystrophin. The accumulated levels of desmin and
dystrophin increased by additional CD overexpression, indicate the coordination of the
protease systems in degradation of individual proteins as well as the role of calpain in
initiating protein degradation.
Numerous studies have shown that calpain cleaved a variety of substratesin
vitro. The second goal of this study was to identif' the actual substrates of m-calpain in
skeletal muscle. A dominant negative m-calpain was used as a bait for screening human
skeletal muscle cDNA libraries in the yeast two-hybrid system. Four partial cDNAs
encoding creatine kinase, glycogen phosphorylase, Ca2tATPase and nebulin-related
protein were identified as m-calpain binding proteins. Purified creatine kinase and
glycogen phosphorylase were cleaved by m-calpain in anin vitroassay. These results
suggest that creatine kinase and glycogen phosphorylase interact with m-calpain and m-
calpain may regulate the degradation of creatine kinase and glycogen phosphorylase
and possibly regulate their activities. To date, we have not yet evaluated whether Ca2-
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scholarship.COORDINATION OF PROTEASE SYSTEMS ON MUSCLE PROTEIN
DEGRADATION AND IDENTIFICATION OF CALPAIN SUBSTRATES
USING THE YEAST TWO-HYBRID SYSTEM
INTRODUCTION
The rate of muscle protein turnover has significant effects on both the rate and
efficiency of skeletal muscle growth. Modulating protease activity in muscle could have
major effects on the rate of muscle protein growth. It has been estimated that 15 to 25%
of food ingested by domestic animals is used to replace muscle protein that is degraded
during metabolic turnover (Young et al., 1975). Therefore, decreasing the rate of protein
degradation would result directly in increased efficiency by which animals convert
nutrients into muscle. In addition, several studies have demonstrated that growth
promotants in livestock stimulate muscle growth through an inhibition of muscle
protein degradation (Yang and McElligott, 1989; Forsberg et al., 1989; Parr et al., 1992;
Pringle et al., 1993).
Protein degradation in a tissue is mediated by a mixture of proteolytic systems
which, presumably, act in concert to mediate the complete disassembly and digestion of
proteins to amino acids. The three major proteolytic systems are the lysosomal,Ca2-
dependent and ubiquitin (Ub)-proteasome pathways. Atrophying muscle is the best
sample of the dramatic changes that can occur in muscle protein mass. The most
common causes of skeletal muscle atrophy are disuse and denervation, systemic
acidosis, systemic metabolic disturbances, glucocorticoid excess and starvation.
Exercise-induced damage, systemic sepsis, and burn injury are also able to stimulate
multiple proteolytic pathways in skeletal muscle (Belcastro et al., 1998; Tiao et al.,2
1994; Hummel et al., 1998; Fang et al., 1995; Voisin et al., 1996; Mansoor et al., 1996).
In such pathological situations, rapid atrophy of skeletal muscle is largely the result of
an increased rate of protein degradation that may be mediated by the Ub-proteasome
system. However, increased activities of calpain and lysosomal proteases are also
observed in these situations (Wing and Goldberg, 1993; Tischler et al., 1990; Baracos et
al., 1995; Weinstein et al., 1997). Hence, there is uncertainty regarding which of the
proteolytic systems plays the key rate-limiting event.
Although there is abundant evidence that each protease system plays a role in a
large number of physiological processes, the specific roles of each protease in muscle
protein degradation have not been established. It is important to learn what enzymes are
involved in degrading particular pools of proteins and individual protein to be able to
understand their regulation.
Calpain is a multifunctional protease discovered in 1964 (Guroff and Guroff,
1964; Meyer et al., 1964). The structural and enzymatic properties of the two most
common isoforms(.t-and m-calpain) are well characterized. Nevertheless, the
physiological function of calpain is not yet well understood. Several lines of evidence
indicate that the calpain system plays an important role in prenatal myoblast fusion and
proliferation of myogenic cells in developing muscle tissue and in initiation of
myofibrillar protein turnover in mature muscle cells (for reviews see Wang and Yuen,
1999). Calpain' s ability to process proteins (instead of completely digesting them)
indicates its significant role in a variety of physiological events. The putative role of
calpain is in remodeling/disassembly of cytoskeleta! and plasma membrane3
interactions (Goll et al., 1992a). We know many cytosolic and myofibrillar proteins are
substrates of calpain. However, there is limited information on the regulation of the
turnover of these substrates in vivo. Based on this, it is of very much interest to assess
the specific roles of calpain in the turnover of individual protein in living cells.
The objective of our research was to understand the flnctions of the proteases
(mainly calpain) in skeletal muscle. The first of two specific aims was to learn how the
muscle protein degradation is regulated in skeletal muscle. We were specifically
interested in learning the role of each protease in degrading particular pools of protein
and specific proteins. In this study, we used cultured rat skeletal muscle cells (L8 cell
line) as a model and assessed the effects of protease inhibitors on muscle protein
degradation. The second aim was to determine the actual substrates of m-calpain in
skeletal muscle and characterize the role of m-calpain in regulating those proteins. We
used the yeast two-hybrid strategy to identif' muscle m-calpain binding proteins from a
skeletal muscle cDNA library.
Results from this study may be used to:
1.Establish the role of the protease system responsible for muscle protein degradation.
2.Regulate the protease system to increase muscle mass or to enhance the efficiency
of muscle growth.
3.Define substrates of calpain in muscle cells.
4.Determine the potential roles of the calpain system in muscle cells and muscle
pathologies.4
LITERATURE REVIEW
Skeletal Muscle and Muscle Proteins
Skeletal muscle is the best known and understood muscle of the four types of
muscle tissue. In addition to its role in movement, it is also an important source of
nutrition during protein and energy deprivation (Scornik Ct al., 1997). Sarcomeres, the
unit of muscle physiological function, comprise the major mass in muscle and permit
contraction for force generation and transmission (Bates and Millward, 1983). The
individual proteins of the myofibrils are continuously undergoing degradation and
synthesis. Both of these processes are dependent on the age of animal, the subtype of
the muscle, activity, health and endocrine states (Bates and Millward, 1983; Allen 1988;
Millward 1980).
Muscle fibers (skeletal muscle cells) originate from the embryonic mesoderm.
The precursors of muscle cells, myoblasts, fuse with one another to form multinucleated
skeletal muscle cells. Once formed, a skeletal muscle cell is generally retained for the
entire lifetime of the animal. Myofibrillar proteins organized as contractile elements
(myofibrils) of the muscle cell and represent up to 80% of total muscle proteins (Goll et
al., 1991). The remaining proteins are classified as non-myofibrillar proteins which
include other sarcoplasmic proteins, nuclear and membrane proteins. The non-
myofibrillar proteins are easily extracted from muscle with low salt buffer whereas the
myofibrillar proteins are soluble in high salt buffer.The arrangement of thick and thin filament gives skeletal muscles a striated
appearance (Fleischer andInui, 1989).The dark or A band of sarcomere contains a set
of parallel thick filaments, which are composed almost entirely of myosin. The light or I
band contains a set of the thin filaments that are anchored to the Z disk. The center of
the sarcomere where actin and myo sin do not overlap is defined as the H band. The thin
filaments consist mainly of actin and two other major proteins, tropomyosin and
troponin. The troponin-tropomyosin complex regulates muscle contraction by varying
the access of myosin heads to their actin binding sites in response to the concentration
ofCa2(Farah and Reinach,1995).Troponin consists of three subunits: TnC, aCa2-
binding calmodulin homolog; TnI, which binds actin; and TnT, which binds
tropomyosin. During muscle contraction, the think and thin filaments maintain constant
lengths whereas Z lines move closer together. Sliding of the thin filaments over the
thick filaments during muscle contraction is produced by breaking and re-forming of the
cross-bridge between actin and myosin. This cyclic process is driven by ATP
hydrolysis. Each single cycle shortens muscle by about 1%.
Many proteins, which are less abundant but perform very important role in
muscle cell, are in the non-myofibrillar fraction. This fraction is rich with glycolytic
enzymes, proteins involved in signal transduction and differentiation control. The Z-
disk contains several fibrous proteins which are required for myofibril assembly and
stabilization (Voet and Voet,1995).For instance, a-actinin attaches thin filaments to
the Z disk. Desmin and vimentin localize at the Z disk periphery. Titin links thick
filaments to Z disk and confers passive elasticity. C-protein and M-protein associatewith the M disk, which arises from the local enlargement at the center of the thick
filaments. Nebulin winds along the length of a thin filament, thereby controlling this
length. Dystrophin is associated with muscle plasma membrane.
Calpain Structure and Properties
Calpain is a calcium-activated cysteine protease that was originally identified in
rat brain (Guroff and Guroff, 1964). Two isoforms (p.- and m-calpain) are well
characterized and several tissue-specific isoforms have been reported (Sorimachi et al.,
1997). p.- and m-calpain, which require a micromolar and a millimolar concentration of
Ca2for activation, respectively, exist ubiquitously in mammalian tissues. Both
isoforms are heterodimers and consist of a unique catalytic (80-kDa) subunit and an
identical regulatory (30-kDa) subunit. The large (80-kDa) subunit can be divided into
four domains (I-IV, Figure 1). Domain II is the cysteine protease domain and its active
site residues are similar to other cysteine proteases such as papain or cathepsins B, L, or
S. Domain IV is a calmodulin-like domain containing five sets of E-F-hand sequences
that are potential Ca2-binding sites. The functions of Domains I and ifi are less clear.
However, the N-terminal region of Domain I is removed during autocatalytic activation
and could play a role in inhibiting the enzyme or preventing access of substrate to the
active site (Saido et al., 1993). Domain III contains two sets of E-F-hand motifs. The
small (30-kDa) subunit comprises two domains (V and IV'). The N-terminal region,
Domain V, is glycine-rich and possibly interacts with membrane phospholipids to
localize or stabilize the enzyme complex"Pre-autolysisCálpain"
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Figure 1. Autolytic activation of calpain. Both large and small subunits undergo
autolysis upon activation, generating new N-termini. Substrate proteolysis follows
autolysis.8
(Sorimachi et al., 1990). The C-terminal portion, Domain IV', also contains five
potential Ca2-binding sites.
Several tissue-specific calpains have been reported. The first discovered tissue-
specific calpain is p94. This is expressed exclusively in skeletal muscle. It possesses
three unique additional segments not found in other calpain species (NS, IS-i, IS-2) and
does not associate with the conventional calpain small subunit (Kinbara et al., 1998).
Muscle-specific p94 is activated and expresses its proteolytic activity at physiological
Ca2concentration. More recently, an alternative spliced variant of p94, Lp82, was
discovered in lens (Ma et al., 1999). nCL-2 is another calpain homologue which co-
exists predominantly in the stomach with nCL-2', its alternatively spliced molecule.
This spicing variant lacks the Ca2tbinding domain and most of Domain III (Sorimachi
et al., 1993), suggesting that the function of nCL-2' is independent of calcium. Various
atypical calpain homologues also exist in lower organisms such as insects, nematodes,
fungi and yeast (Ono et al., 1998; Sorimachi et al., 1997). Those proteins share
conserved structures similar to the conventional calpain large subunit (Domains I and
II). Interestingly, most of these homologues contain other unique domains which are
likely responsible for the many unique functions they possess.
Regulation of Calpain Activity and Autolysis
Calpain autolysis is necessary for expression of its catalytic activity. Autolysis
of calpain is initiated upon the increase of intracellular Ca2 concentration. Autolysis
removes the N-terminal 19 or 27 (rn- or ji-calpain) amino acids from the 80-kDapolypeptide and the N-terminal 91 amino acids from the small polypeptide (Suzuki
1990). TheCa2concentration required for half-maximal activity of calpain measuredin
vitro ranges from 3-50 jiM for p.-calpain and 400-800 jiM for m-calpain (Cong et al.,
1989; Kapprell and Goll, 1989). TheCa2concentration required for various properties
of calpain is significantly higher than the physiologicalCa2concentration in the cells
(Harkins et al., 1993). Increases in intracellular free [Ca2] up to 1-2 pM result in
increased calpain activity (Hong et al., 1994; Turner et al., 1991) indicating that calpain
responds to the fluctuation of freeCa2and does not require the highCa2concentration
indicated inin vitroassays. WhenCa2concentration increases, translocation of calpain
to the membrane was observed following by calpain activation (Saido et al., 1993). The
autolyzed form is then released from the membrane (Pontremoli et al., 1985). N-
terminal modification enhancesCa2sensitivity of calpain since the autolyzed forms
apparently require lessCa2concentration for their activity. Binding to phospholipids in
the cell membrane lowers theCa2concentration required for calpain autolysis (Goll et
al., 1992b). And, it was shown that calpain also binds to proteins in erythrocyte
membranes (Kuboki et al., 1990) and in membrane vesicles (Inomata et al., 1989).
Thus, membrane proteins, as well as phospholipids, are thought to provide important
interaction sites. Recently, the membrane-associated activator specific for p.-calpain and
m-calpain was detected in rat brain and skeletal muscle, respectively (Melloni et al.,
1998; Michetti et al., 1991). The activator competes with calpastatin for the binding of
the catalytic 80-kDa subunit, increasing itsCa2sensitivity and promoting the
dissociation of calpain' s heterodimeric structure.10
It has been postulated that 30-kDa subunit acts as an inhibitor or pseudo-
sub strate. The dissociation of calpain into subunits happens as a consequence of
autolysis and in the presence of Ca2. The dissociated large subunit alone retains full
catalytic activity (Yoshizawa et al., 1995). The large subunit expressed in the
bacculovirus/Sfcell system is fully active without the co-expression of the small
subunit (Vilei et al., 1997). Therefore, the small subunit is important but not necessary
for calpain activation; it may contribute to the proper folding of the large subunit.
The activity of calpain is also regulated by its endogenous inhibitor, calpastatin.
Calpastatin is expressed ubiquitously in mammalian cells. Two forms of calpastatin
(muscle type and erythrocyte type) exist from a result of alternative splicing of a single
calpastatin transcript (Geesink et al., 1998). Under physiological conditions in which
Ca2concentration is lower than those required to initiate proteolytic activity,
calpastatin binds to calpain and completely inhibits all isozymes of calpain in a
substrate-competitive manner (Kawasaki and Kawashima, 1996). One molecule of
calpastatin can interact with four calpain molecules. The interaction of calpain and
calpastatin is calcium-dependent (Kapprell and Goll, 1989).
Role of Calpain in Muscle Growth and Muscle Pathologies
Calpain is a housekeeping enzyme that is expressed constitutively. Hence, it
performs common functions in all cells. These functions include embryonic myoblast
fusion and differentiation (Barnoy et al., 1998; Balcerzak Ct al., 1998), cytoskeletal
protein degradation and remodelling, membrane protein degradation (Saido et al.,11
1994), activation of protein kinase C isoforms and degradation of membrane-bound
hormone receptors (Go!! et al., 1989). On the other hand, calpain analogues with tissue-
specific expression patterns indicate that they are pivotal to tissue development,
maintenance, or function (Sorimachi et al., 1989). Calpain is also considered to be a
regulator of calcium-dependent cell functions (Goll et al., 1992a; Suzuki et al., 1995). In
skeletal muscle, calpain initiates degradation of the sarcomeric complex by degrading
proteins such as titin, nebulin, desmin, C-protein, M-protein, filamin and certain Z-disk
proteins. This releases thick and thin filaments from the surface of myofibrils for
digestion by other proteases (Solomon and Goldberg, 1996). Proteasome, the major
cytosolic proteolytic mechanism, has no effect on proteins in intact myofibrils and
intact myofibrils have never been observed in lysosomal structures, even in rapidly
atrophy muscle (Solomon and Goldberg, 1996; Koomaraie 1992). However, both
protease systems rapidly degrade individual myofibrillar proteins. Indeed,
immunocytochemistry has revealed that 5% of muscle calpain is associated with the Z-
disk and it has been proposed that this fraction accounts for the normal turnover of
myofibrillar proteins (Goll et al., 1992a; Ishiura et al., 1980).
Calpain is also involved in normal muscle skeletal growth. Administration of
various 3-adrenergic agonists to animals results in a 10-30% increase in rate of
accumulation of muscle mass (Yang and McElligott, 1989). Muscle calpastatin activity
is significantly increased upon exposure to beta-agonists (Forsberg et al., 1989; Parr et
al., 1992; Pringle et al., 1993). Some studies have found that m-ca!pain activity
increases whereas muscle -ca1pain is decreased or unchanged (Higgins et al.,12
1988; Koomaraie and Shackelford, 1991; Wang and Beermann, 1988). These results
suggest that 3-adrenergic agonists increase rate of skeletal muscle growth by decreasing
rate of protein degradation via a calpastatin-dependent event.
Calpain is activated when cells are injured and cytosolicCa2rises. Therefore,
calpain plays an important role in tissue injury, necrosis and autolysis (Goll et al.,
1992a). Calpain is also involved in numerous pathological events such as stroke, brain
trauma, Alzheimer' s disease, cardiac ischaemia, muscle dystrophy, aging, sepsis,
cataract, thrombolic platelet aggregation, arthritis and malaria (Saido et al., 1994; Wang
and Yend, 1994; Wang and Yuen, 1999). Recent investigations of calpain activation
response to muscle injury have provided additional evidence ofcalpains'involvement in
membrane reorganization, myofibril dissolution and the regeneration of replacement
fibers following muscle injury and inflammatory response (Belcastro et al., 1998). More
recently results have indicated a key role for calpain in apoptosis (Villa et al., 1998).
Calpain Substrates
In vitro, calpain cleaves a variety of substrates. These include cytoskeletal
proteins (spectrin, integrin, fibronectin, desmin, vimentin, cadherin, talin, ankyrin,
fodrin, filamin); myofibrillar proteins (troponin, tropomyosin, myosin light chain
kinase, nebulin, C-protein, M-protein); soluble and membrane-associated enzymes
(protein kinase A, protein kinase C, phospholipase C); receptor proteins (EGF receptors,
ryadodine receptor); cytokines (interleukin 1 a); transcription factors (Fos, Jun) and lens
proteins (crystallins) (Potter et al., 1998; Belcastro et al., 1998; Shoshan-Barmatz et al.,13
1994; Kawasaki and Kawashima, 1996). Calpain does not degrade proteins to small
peptides or amino acids. Rather, cleavage occurs at specific sites, leaving large
polypeptide fragments with altered physiological properties.
Although numerous proteins are cleaved by calpainin vitro,there is limited
information on calpain regulation of those substratesin vivo.Shuster and Herman
(1995) demonstrated that ezrin, the ERM protein located at the actin-membrane
interface, is an in vivo substrate of p.-calapin. Ezrin is markedly increased in NIH-3T3-
derived cell lines that stably overexpressed calpastatin (Potter et al., 1998). Inhibition of
calpain by overexpression of calpastatin inhibitory domain and dominant-negative m-
calpain in L8 cell lines also stabilized nebulin and fodrin (Huang and Forsberg, 1998).
Studies by Sorimachi and colleagues (Sorimachi et al., 1995; Kinbara et al., 1998),
using yeast two-hybrid approach to demonstrate protein-protein interaction in vivo,
identified titin/connectin as p94-binding proteins. In addition, Shinozaki et al. (1998)
demonstrated that the presenilin 2 loop domain (PS 2, a gene responsible for the early-
onset familial Alzheimer' s disease) binds to t-calpain and may, therefore, be a calpain
substrate.
The Protease Systems and Cellular Protein Degradation
The rate of protein degradation in a tissue is dependent upon physiologicalstate
and is mediated by a mixture of proteolytic systems which, presumably, act in concertto
mediate the complete disassembly and digestion of proteins to amino acids. The
turnover of skeletal muscle proteins, which are an important source of nutrition during14
protein and energy deprivation (Scornik et al., 1997), is regulated by three major
proteolytic systems: the lysosomal, Ca2tdependent and Ub-proteasome pathways. The
Ub-proteasome pathway was first demonstrated in the late 1970s and shown to
selectively catalyze breakdown of abnormal and short-lived proteins (Goldstein et al.,
1975; Etlinger and Goldberg, 1977). However, this system is also responsible for the
turnover of the long-lived proteins that comprise the vast majority of intracellular
protein (Rock et al., 1994). In this pathway, proteins are targeted for degradation by
covalent ligation to ubiquitin and degraded by the 26S proteasome complex which
digests proteins to small peptides (Kisselev et al., 1998). In catabolic conditions suchas
uremia, activity of the Ub-proteasome pathway increases. This is accompanied with
increased levels of ubiquitin mRNA and mRNAs encoding multiple subunits of the
proteasome and results in degradation of muscle proteins (Ding et al., 1997). The Ub-
proteasome pathway is also activated in response to starvation, sepsis, muscle
denervation, cancer, thermal injury and acute diabetes (Temparis et al., 1994; Wing and
Goldberg, 1993; Ding et al., 1997; Wing et al., 1995; Baracos et aL, 1995; Tiaoet al.,
1994).
Lysosomal proteases (cathepsins) are known to degrade endocytosed proteins.
Most of the lysosomal proteases are cysteine proteases with the exception of cathep sins
G and cathepsins A (serine proteases) and cathepsins D and cathep sins E whichare
aspartate proteases (Otto and Schirameister, 1997). Exogenous and endogenous
proteins, which are taken up by the cell via endocytosisor autophagocytosis, are
transported in the form of endosomes or autophagosomes and finally directedto the15
lysosomal pathway by fusion of these vesicles to lysosomes. Proteins can be degraded
to amino acids in the lysosomes. In addition to non-specific protein degradation,
cathepsins may play a role in specific processing of proteins (Quinn and Judah, 1978;
Bond and Barrett, 1980), degradation of collagen, fibrinogen, and histones, in bone
degradation (Otto and Schirameister, 1997) and protein breakdown in sepsis (Hummel
et al., 1998). Studies with rat soleus muscle have shown that lysosomal proteolysis is
involved in atrophy of denervated muscle (Tischler et aL, 1990; Weinstein et al., 1997).
This indicates that co-ordination of the various protease systems occur during periods of
muscle atrophy.
Observation with different types of muscle wasting has shown that both
lysosomal and Ca2tactivated proteases contribute to muscle proteolysis. The Ub-
proteasome-dependent process appears mainly responsible for the rapid loss of cell
proteins, especially of myofibrillar components (Temparis et al., 1994; Mitch et aL,
1994; Furono et al., 1990; Whipple and Koomaraie, 1991). Studies on different
proteolytic pathways in L6 myotubes (Fernandez and Sainz, 1997) have indicated that
degradation of sarcoplasmic and myofibrillar proteins are independently regulated. Both
lysosomal and non-lysosomal proteolytic pathways are involved in regulation of total
protein degradation in L6 myotubes. Similar investigation with C2C12 myotubes
(Ebisui et al., 1995) demonstrated that both lysosomal and proteasome systems
participated in the IL-6-induced degradation of long-lived intracellular proteins. These
observations have shown protein turnover in muscle cells are mediated by a mixture of16
proteolytic systems. However, it is unclear of which substrates are degraded by
individual protease and how the proteases are regulated.
Protease Inhibitors
All endogenous cysteine protease inhibitors (cystatin superfamily) can inhibit
calpains, lysosomal enzymes and the proteasome. Calpain is specifically inhibited by its
endogenous inhibitor calpastatin. Calpastatin can prevent both enzymatic activation and
the expression of calpain catalytic activity. Calpain and calpastatin are co-localized
(Kumamoto et al., 1992) and calpastatin activity exceeds calpain activity in many cells
(Kawasaki and Kawashima, 1996). Calpastatin was first cloned in 1987 (Emori Ct al.,
1987) and its sequence is not homologous to any known polypeptide including the
cystatins, which inhibit many of the cysteine proteases. Different calpastatin
polypeptides can be produced by either alternative splicing, from different start sites of
translation or from transcription of the calpastatin mRNA or gene (Cong et al., 1998;
Lee et al., 1992b). Most calpastatin molecules comprise four repeating domains plus an
N-terminal domain and domain L/XL (Figure 2). Each of repeated domains can bind
one calpain molecule and possess inhibitory activity (Maki Ct al., 1987;Emori et al.,
1987). Use of BlAcore instruments to examine the interaction site between calpastatin
and calpain (Takano et al., 1995) has revealed that three sub-domains of the reactive site
of calpastatin bind to Domain IV of the large calpain subunit, the active site and
Domain IV' of the small subunit, respectively. Interestingly, the muscle-specific17
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Figure 2. Schematic diagram showing the domain structure of bovine cardiac
calpastatin. A human erytbrocyte calpastatin lacks domain XL, L and domain I (Imajoh
et al., 1987). Rabbit and human skeletal muscle calpastatins do not have domain XL
(Emori et al., 1987; Lee et al., 1992b).18
calpain, p94, which does not associate with the small subunit (Kinbara et al., 1998), is
not inhibited by calpastatin (Sorimachi et al., 1995).
As for synthetic inhibitors, a variety of peptidic, peptide mimetic and non-
peptide inhibitors have been recently developed. Calpain inhibitors I and II, calpeptin,
leupeptin, and E-64, a naturally occurring epoxysuccinate first isolated from fungi, and
its derivatives (E-64c and E-64d) are widely used (Sorimachi et al., 1997; Gregory and
Bihovsky, 1998; Hanada et al., 1978). Although these inhibitors efficiently inhibit both
.t-and m-calpains, they are not very specific as they also inhibit other cysteine
proteases and the proteasome as well (Figueiredo-Pereira et al., 1994; Tsubuki et al.,
1996). PD 150606, a ct-mercaptoacrylic acid derivative, is a relatively potent, selective
and reversible calpain inhibitor developed by Wang and colleagues (Wang et al.,
2+ 1996a). PD 150606 has a distinct inhibitory mechanism. It binds to the Ca -binding
domain of calpain (Lin et al., 1997) and thereby interferes with calpastatin binding.
Other inhibitors such as chloroquine, methylamine and NH4C1 are commonly used in
lysosome studies (Tischler et al., 1990; Baracos et al., 1995; Gordon and DeMoss,
1999; Myers et al., 1995; Minor et al., 1991).
Protein-Protein Interaction Studies and the Yeast Two-Hybrid System
Protein-protein interactions are intrinsic to virtually every cellular process.
Protein-protein interactions have generally been studied using biochemical techniques
such as cross-linking, co-immunoprecipitation, protein affinity chromatography, affinity
blotting, and library-based methods i.e. protein probing, phage display and two-hybrid19
system (Phizick and Fields, 1995). Functional protein-protein interactions using the
yeast two-hybrid techniques have been detected for all levels of cellular biology
(Estojak et al., 1995; Young 1998; Dress 1999) since it was developed in 1989 (Fields
and Song, 1989). The yeast two-hybrid system takes advantage of the properties of the
GAL4 protein of Saccharomyces cerevisiae. This protein is a transcriptional activator
required for the expression of genes encoding enzymes for galactose utilization. The
GAL4 protein consists of two separable and functionally essential domains: an N-
terminal domain which binds to specific DNA sequence (UAS); and a C-terminal
domain containing acidic regions, which is necessary to activate transcription. The
system of two hybrid proteins contain portions of GAL4: the GAL4 DNA-binding
domain fused to a protein 'X' and a GAL4 activating region fused to a protein 'Y'. If X
and Y can form a protein-protein complex and reconstitute proximity of the two GAL4
domains, transcription of a gene regulated by UAS occurs (see Figure 3). Examples of
protein partners that have been detected by this system include CDK6 and its inhibitor,
p18 (Guan et al., 1994), c-jun/c-fos (Kato et al., 1992), p53/T-antigen (Li and Fields,
1993), the growth factor receptor-associated protein Grb2 and human Sosi guanine
nucleotide exchanger (Chardin et al., 1993), Ras and the protein kinase Raf (Vojtek et
al., 1993), and protein phosphatase PP1a2 and Rb (Durfee et al., 1993).20
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Figure 3. The two-hybrid system. A: The GAL4 DNA-binding domain hybrid does not
activate transcription if protein X does not contain an activation domain. B: the GAL4
activation domain hybrid does not activate transcription because it does not localize to
the DNA-binding site. C: Interaction between X and Y reconstitues GAL4 function and
results in expression of the reporter gene.21
MATERIALS AND METHODS
Coordination of Proteases in Control of Muscle Protein Degradation
Myoblast cultures
Rat myoblast L8 cells were cultured in Dulbecco's Modified Eagle Medium
(DMEM, Gibco, Gaithersburg, MD) with addition of 1000 mg/i D-glucose, 584 mg/i L-
glutamine, 110 mg/i sodium pyruvate, 4 mg/i pyridoxine hydrochloride, 3.7 g/l sodium
bicarbonate, 100 U/mi Penicillin-100 p.g/ml Streptomycin (Cellgro Mediatech,
Herndon, VA) and 10% fetal bovine serum (characterized FBS, Hyclone, Logan, UT).
When cells reached 90-95% confluence, the medium was changed to DMEM complete
medium containing 2% horse serum (Hyclone) in order to obtain filly differentiated
myotubes. The medium was changed every other day for either myoblast or myotube
maintenance.
For long-term storage or subculture, adherent cells were detached from the plate
by trypsinization with 2.Smg/ml trypsin (GibcoBRL, Gaithersburg, MD) and 3-mm
incubation at 37°C. PBS medium was immediately added to stop further trypsinization.
Suspended cells were centrifuged at 1000 rpm for 5 mm and the supernatant was
discarded. For subculture, the cells were evenly distributed on new plates. For storage,
the cells were placed in vials with a 10:1 ratio of FBS medium and DMSO (Sigma, St.
Louis, MO) and stored at -80°C or in liquid nitrogen.22
Measurement of total protein de2radation and stability of individual proteins
Calpastatin inhibitory domain-transfected myoblast L8 cells (L8/CID cells;
Huang and Forsberg, 1998) were cultured in 5-cm culture dishes (Corning, NY) in the
medium containing hygromycin B (200 p.g/ml; GibcoBRL) and geneticin (400 p.g/ml;
GibcoBRL) to maintain the existence of the transgenes. Total protein degradation was
estimated from the rate of production of free tyrosine from pre-labeled muscle proteins
(pulse-chase experiment; Goldberg and St. John, 1976). Each treatment was completed
in triplicate. At 90-100% differentiation (day 6), L8/CJD cells were cultured for 24 hr in
the presence of 0.33 j.tCi/ml of[3H] tyrosine (42.3 Cilmmol; NEN, Boston, MA) with
and without isopropyl 3-D-thiogalacto-pyranoside (IPTG; CD inducer, Sigma, St.
Louis, MO) or methylamine (5-20 mM; lysosomal protease inhibitor, Sigma) or Z-Leu-
Leu-Leu-H (aldehyde) (ZLLL, 15-100 nM; proteasome inhibitor, Peptide Institute,
Osaka, Japan) or combination of the inhibitors. Following this, three plates of L8/CID
myotubes were taken and processed for determination of the initial levels of
radioactivity associated with protein fractions. In the remaining plates, the radioactive
media were removed and the cultures were washed twice and refilled with DMEM
containing 2 mM tyrosine (chase; Sigma). At this time, 1.5 ml of medium were taken
from each plate and radioactivity was measured to determine the radioactivity present at
time zero. The plates were cultured for an additional 6, 12 or 24 hr. At the end of
incubation, 1.5 ml of medium were taken from each plate, treated with 10% TCA (final
w/v) and precipitated by centrifugation at l4000xg for 10 mm. The supernatants were
then measured for radioactivity. From these measurements, total protein degradation23
(D) and the percentage reduction of protein degradation (R) caused by IPTG and
inhibitors were calculated as follows: D = radioactivity at time 6, 12 or 24 hr-
radioactivity at time 0 and R = 100 x DDjjbitor/D. Stabilities of individual proteins
(eg. ct-actinin, filamin, desmin, m-calpain, tropomyosin and dystrophin) were assessed
using Western blot analysis.
Preparation of muscle myofibrillar- and non-myofibrillar protein-rich fractions
The muscle samples were fractionated into sarcoplasmic and myofibrillar
fractions. To accomplish this, muscle samples were washed twice with phosphate-
buffered saline (PBS) and were scraped from the culture dishes and resuspended in 1 ml
of low salt buffer (40 mM NaCI, 1 mM dithiothreitol, 0.1 mM EOTA, 0.1% Triton X-
100 in 5 mM sodium phosphate, pH 6.8). Cells were then homogenized using a Dounce
homogenizer with 15 strokes of a tight fitting pestle. The homogenate was centrifuged
at l000xg for 10 mm. The pellet containing myofibrillar proteins was dissolved in 1 ml
of 0.5 N NaOH with 0.1% Triton X-100. The supernatant contained sarcoplasmic (non-
myofibrillar) proteins. To this 10% TCA (final w/v) was added and the mixture was
chilled at 4°C for 1 hr. After centrifligation at l4000xg for 10 mm, the pellet was
dissolved in 1 ml of 0.5 N NaOH with 0.1% Triton X-100. Nine ml of EcoLume Liquid
Scintillation Cocktail (ICN, Costa Mesa, CA) was mixed with the protein fractions. The
radioactivity in the protein fractions was then counted in liquid scintillation counter.24
Preparation of protein extracts from cultured cells
Cell protein was recovered according to Wang et al. (1996b). Following
treatments, cells were washed twice with PBS and lysed at room temperature for 5
mm by adding 500 .tl of SDS lysis/protease inhibitor solution (20 mM Tris-Cl pH 7.4,
150 mMNaC1, 5 mMEDTA, 5 niMEGTA, 2% SDS, 0.5 mMPMSF (Boehringer
Mannheim, Indianapolis, iN), 10 pg/ml 4-(2-aminoethyl)-benzene-sulfonylfluoride
(AEBSF) hyhrochloride (Sigma), 5 jtg/ml leupeptin (Sigma), 10 pg/ml N-tosyl-L-
phenylalanine chioromethyl ketone (TLCK; Sigma), 10 p.g/ml TPCK (Sigma), 10
tg/ml E-64 (Peptide International, Louisville, KY) and 0.37 mg/ml aprotinin (Sigma).
One hundred p.1 of 100% TCA were added to the lysate and the DNA aggregate was
removed. The lysate was then centrifuged at 3600xg for 5 mm. Pellets were washed
with 1 ml of 2.5% TCA (w/v), neutralized and dissolved in 25-50 p.1 of 3 M Tris base.
Protein concentration in the lysate was determined by the method of Lowry et al.
(1951). Aliquots of protein lysate were separated by SDS-PAGE and analyzed by
immunoblotting.
SDS-PAGE and Western blots
Proteins were subjected to SDS-PAGE (6.5-10%) according to Laemmli (1970).
The gel was run at 120V until the bromophenol blue dye front reached the bottom of the
gel. After electrophoresis was completed, the gel was either stained with Coomassie
blue or transferred to the electroblotter apparatus (BioRad, Hercules, CA). The proteins
were electrotransferred to Optitran nitrocellulose membranes (Schleicher & Schuell,25
Keene, NH) overnight at 30V, followed by 2 hr at 60V. Non-specific sites on the
membrane were blocked with 5% non-fat dry milk and 1% BSA in TBST (20 mM Tris-
HC1 pH 7.6, 137 mM NaC1, 0.1% v/v Tween 20) for 1 hr. The membrane was then
incubated for 2 hr with monoclonal antibody against a-actinin (1:3500, Sigma), filamin
(1:1500, Sigma), desmin (1:1000, Sigma), dystrophin (1:2000, Sigma), tropomyosin
(1:1000, Sigma), lac I (1:1000; polyclonal, Stratagene, La Jolla, CA) and m-calpain
(1:850; rabbit anti-rat polyclonal prepared in our laboratory). The bound antibody was
detected by 1-hr incubation with conjugated secondary antibody. Detection of bands
was carried out with the ECL immunoblotting detection system (ECL, Amersham
Pharmacia, Piscataway, NJ). Blots were quantified by scanning densitometry. The
Object Average method of Image QuaNT, Molecular Dynamics software, was used to
determine the amount of each image based on the area and intensity of the blot.
Cell Toxicity assay
To examine if inhibitors and IPTG were toxic to the cells. Toxicity of cultured
cells was assayed by using Cytotoxicity assay kit (Promega, Madison, WI). In this
assay, amounts of lactate dehydrogenase (LDH) which leaked into the medium were
detected. Briefly, 50 Rl of cell culture medium was incubated with 50 d of substrate
mix for 30 mm in the dark. The reaction was stopped by adding 50 p.1 of stop solution.
0D490 of treated sample was compared to that of untreated sample to assess cell toxicity.26
Statistical analysis
In the studies of total protein degradation, each experiment was repeated twice
for ZLLL and methylamine treatments and at least three times for IPTG treatment.
Triplicate measurements were made for each experiment. The data were analyzed
using multifactor ANOVA for the effects of different experiments. Scheffe's statistic
was used to test the contrasts, the comparison of each concentration to control (no
inhibitor). The experiments with small numbers of contrasts were tested by comparison
to Bonferroni t statistic.
For the experiments with the combined treatments, each experiment was
repeated three times using three replicates for each treatment. The experiment effects
and comparison of each treatment to control (no inhibitor at 24 hr after serum
withdrawal) were assessed using multifactor ANOVA and Scheffe's statistic,
respectively. Paired t-test was used to test the difference of control at 0 hr and 24 hr
after serum withdrawal. A level of significance of 5% was adopted for all comparisons
and the SAS system for windows was used as the statistical software.
Identification of Calpain Substrates Using the Yeast Two-Hybrid System
Plasmid construction
Construction of dominant negative m-calpain: Full length human i- and m-calpain
cDNA, cloned into expression plasmid, pAS2-1 (pASp.CL and pASmCL, respectively;
Figure 4), was kindly provided by Hiroyuki Sorimachi (University of Tokyo, Japan).DNA-BD vector: pASZ-1
27
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Figure 4. Expression vectors in the yeast two-hybrid system. The diagrams show genes
necessary for selection and screening in the yeast two-hybrid system. Calpain cDNAs
were subcloned into pAS2-1, fused in-frame to GAL4-DB. Library cDNAs were
inserted undirectionally into pGAD1O's EcoRl site.28
Active site mutagenesis of m-calpain was conducted by polymerase chain reaction
(PCR) using pASmCL as a template with a forward primer FPC1O5A (5'-AGG AGC
CCT AGG TGA CGC CTG GCT G-3') and a reverse primer RPhm8O8 (5'-GGC TCC
GGT GAC CGA GTA COC GTG -3'). The optimal conditions for PCR reaction
consisted of 2 mM MgC12, 0.2 mM dNTPmix, 10 p.! Taq DNA polymerase buffer, 2 p.1
(20 ng) DNA template, 1 p.1(50 prnol) forward primer, 1 p.1(50 pmol) reverse primer,
0.5 p.1 Tag DNA polymerase (5 u/p.!, Promega, Madison, WI), and water to make 100
p.1. To generate active site-mutated DNA fragments, PCR was performed for 35 cycles
of 94°C for 1 mm, 66°C for 50 sec, and 72°C for 1 mm. The AvrII-BstEII-cut PCR
fragmentes were then inserted into pASmCL (a plasmid carrying GAL4-BD-hm-calpain
fusion cDNA) cleaved with AvrII and BstEIIto create pASmCLDN. Correct orientation
and composition of the insertion were confirmed by DNA sequencing. All restriction
endonucleases and T4 DNA ligase were obtained from New England Biolabs, (Beverly,
MA).
Construction ofautolyticfornis of m-calpain (78DN): The 78K autolysed form
(Nishimura and Go!!, 1991) of dominant negative m-calpain (mCLDN) was generated
from pASmCLDN by PCR with NcoI-containing forward primer 78khmfp (5'-TTA
TCC ATG GAA TCC CAC GAG AGG GCC ATC AAG TA-3') and Sail-containing
reverse primer pashmrp (5'-TGC AGO TCG ACG GAT CAA TCA GAG AT-3'). The
reaction for generating the 78K fragments was accomplished under 35 cycles of 94°C
for 1 mm, 58°C for 50 sec and 72°C for 2.30 mm. The 78K DNA fragment was then
subcloned into pAS2-1 (Figure 4; Clontech Laboratories, Palo Alto, CA) to create29
pAS78DN. Correct in-frame and orientation of the inserts were confirmed by DNA
sequencing.
Constructionofdomain I V-deleted 78K m-calpain (78z14): The forward primer
78khmfp and Sail-containing reverse primer pasMrp (5'-GAG TCG TCG ACC TCC
ATC ATC AAT GTC ATC CTC G-3') were used to amplify 78A4 fragments from
pAS78DN plasmid. The PCR reaction was accomplished under 35 cycles of 94°C for 1
mm, 60°C for 50 sec and 72°C for 2 mm. DNA fragment 78M was then subcloned into
pAS2-i (Clontech, Palo Alto, CA) to create pAS78A4. Correct in-frame and orientation
of the inserts were confirmed by DNA sequencing.
Preparation of library plasmid DNA
A pre-made human skeletal muscle cDNA plasmid library (Figure 4; Clontech,
Palo Alto, CA) was amplified on solid medium to minimize uneven amplification of the
individual clones. Briefly, the E. coil library transformants were plated directly onto
LB/amp plates at high density (20,000 colonies/i 50-mm plate). Following overnight
incubation at 37°C, the colonies were scraped into 2L of LB/amp broth and were
incubated at 37°C for 3 hr with shaking. The cells were collected by centrifugation.
CsC1 gradient purification was used to isolate the plasmid libraries (Heilig et al., 1994)
Preparation of yeast competent cells for library transformation
The modification of lithium acetate (LiAc) method developed by Ito et al.
(1983) was used for preparing yeast competent cells. S.cerevisiaestrain Y190 (MATa,cii
h&, leu) or Y187 (MATa,his, trp, let!)were inoculated into YPD or appropriate
selective media, vortexed to disperse any clumps, and transferred into 150 ml of YPD.
The culture media were incubated at 30°C for 16-18 hr with shaking at 250 rpm.
Overnight culture was transferred to 1L of YPD to produce an 0D6000.2-0.3,
incubated at 30°C for 3 hr with shaking at 230 rpm. The cell pellet was collected by
centrifugation at l000xg for 5 mm, washed once in water, and resuspended in 8 ml of
freshly made TE/0. 1M LiAc (lx) solution (Sigma).
Yeast transformation
The LiAc-mediated method modified by Schiesti and Gietz (1989), Hill et al.
(1991), and Gietz et al. (1992) was used to introduce DNA into yeast. In the DNA
library transformation, sequential transformation was preferred to simultaneous
transformation because it typically resulted in transformation efficiencies ofi05per .Lg
of DNA when using a single type of plasmid and it used less plasmid DNA. Shortly, 8
ml of yeast competent cells in TE/LiAc solution were mixed with 0.75-1 mg of the
library plasmid (0.5-0.75 mg library plasmid +1 mg bait plasmid for co-transformation)
and 10 mg of herring testes carrier DNA (20 mg for co-transformation). Polyethylene
glycol (PEG)fLiAc solution (40% PEG, Sigma: 1xTE: lxLiAc, Sigma) was then added
and the mixture was incubated at 30°C with shaking. After the incubations, DMSO
(Sigma) was added to 10% (vlv) and mixed gently by inversion. The cells were heat-
shocked for 15 mm in a 42°C water bath and placed on ice for 5 mm. The pelleted cells
were collected by centrifligation for 5 mm at l000xg. The cells were resuspended in 1031
ml of TE buffer (pH 7.5) and were then plated on the synthetic dropout (SD) medium
(SD/-leu,-trp,-his,+3AT) to select for transformants containing the plasmid(s) that
expressed 3-galactosidase and histidine-3 genes (Figure 5). The transformation
efficiency was determined by the number of colonies growing on SD medium that
selected for only one of the plasmids (e.g. SD/-leu medium for library plasmid and SD!-
trp medium for bait plasmid). The co-transformation efficiency was determined by the
number of colonies growing on SD/-leu,-trp medium that selected for both plasmids.
Cycloheximide selection
Cycloheximide was used to select for colonies that had lost the DNA-BD/bait
plasmid (Guthrie and Fink, 1991). A colony of yeast cells carrying two different
plasmids (i.e. the DNA-BD/calpain plasmid and the AD/library plasmid) was
resuspended in 200 il of water and 10-100 p.1 of the cell suspension were spread on
SD/-leu medium containing 10 p.g/ml cycloheximide. The plates were incubated at 30°C
for 3-5 days until individual Cyh' colonies appeared. The DNA-BD/calpain plasmid
that contained the wild-type CYHS2 gene would render yeast host strains Y190 to
become sensitive to cycloheximide. Therefore, the AD/library plasmid would be
retained while the DNA-BD/calpain plasmid had spontaneously been lost from the cell.
The loss of pAS2-1 plasmids was verified by transferring the Cyh' colonies to SD/-trp
plates. Colonies that had lost pAS2-1 plasmids would not grow.32
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Figure 5. Schematic diagram of using the yeast two-hybrid system toscreen cDNA
library for an interaction between two proteins.33
Yeast mating
A haploid state of yeast strain Y190 and Y187 which differed physiologically in
mating types can reproduce sexually by cellular and nuclear fusion to produce a diploid
organism. Therefore, it was used to verify that the candidate AD/library proteins
identified in the two-hybrid library screen could activate the reporter genes only in the
presence of the DNA-BD/target protein. In the mating procedure, various control
plasmids and candidate plasmids to be tested were transformed into proper hosts and the
mating pairs were set up as listed in Table 1. One colony of each type was placed in a
1.5-mi microcentriflige tube containing 0.5 ml of YPD medium. The medium was
vortexed and incubated at 30°C with shaking at 250 rpm for 8 hr. The mating culture
was then spread on SD/-trp,-leu and SD/-trp,-leu,-his,+3-AT plates. The plates were
incubated at 30°C for 4-5 days or until diploid cells appeared.
Table 1. Yeast mating partners to eliminate false positives
Plasmid 1 in Y 187Plasmid 2 in Y 190LacZ phenotype His3 phenotype for
(MATct) (MA Ta) for a true positivea true positive
pAS2-1 pACT2 white no growth
(DNA-BD) (AD)
pAS2-1/calpain pACT2 white no growth
(DNA-BD/calpain)
pAS2-1 pGAD 10/librarywhite no growth
(AD/target)
pAS2-1/calapin pGAD 10/libraryblue positive growth
pLAM5' pACT2/library white no growth
(DNA-BD/control)34
B-Galactosidase Assays
Colony-hftfilter assay:The filter assay was primarily used to screen large numbers of
transformants that survived the H1s3 growth selection in a GAL4 two-hybrid library
screening and also was used to assay for interactions between two known proteins. A
filter was placed over the surface of the plate of fresh colonies to be assayed (grown at
30°C for 2-4 days), then carefully lifted off the agar plate and was placed in a -80°C
freezer with the colonies facing up for at least 1 hr. The filter was allowed to thaw at
room temperature. This freeze-thaw cycle lyses yeast cell walls and permeabilizesthe
cells. The filter was then placed, colony side up, on presoaked filters (in Z buffer/X-Gal
solution; Sigma) and incubated at room temperature until the appearance of blue
colonies. The blue color indicates the expression of lac Z reporter gene.
Cultureassay using ONPG assubstrate: One colony of each lac Z-positived and
control yeast were cultured overnight in 5 ml YPD medium. Two ml of the overnight
cultures were transferred to 8 ml YPD medium and the fresh culture was incubated at
30°C with shaking until0D600of 1 ml cultures reached 0.5-0.8. The cells from 1.5 ml
cultures were washed twice with 1.5 ml of Z buffer and, after the last wash, the pelleted
cells were resuspended in 300 tl of Z buffer. One hundred .t1 of the cell suspension was
transferred to a new microcentrifuge tube. Cells were then frozen in liquid nitrogen and
thawed in 37°C water-bath for 1 mm. The freeze/thaw cycle was repeated three more
times. 3-galactosidase activity in the cell lysate was measured by adding 0.7 ml of Z
buffer/3-mercaptoehtanol (0.27% v/v) and 160 jil of ONPG (4 mg/mi; Sigma) in Z
buffer. After the yellow color was developed, 0.4 ml Na2CO3 was added. The reaction35
tube was then centrifuged at l4000xg for 10 mm. Absorbance of the supernatant was
read at 0D420 against a blank in which 100 p1 of Z buffer replaced the cell suspension in
the reaction. 3-galactosidase units were calculated by 1 000x 0D420/(TxVxOD600);
where "T" was elapsed time in minutes (from ONPG addition to color development)
and "V" was 0.1 x the concentration factor (= 5).
Protein extraction of yeast culture for Western blot
Five ml of overnight culture in SD selection medium of transformed yeast strain
was prepared from a single isolated colony. The cultures were vortexed andinoculated
into 50 ml of YPD medium. After incubation at 30°C with shaking until the 0D600 had
reached 0.4-0.6, the cultures were quickly chilled and centrifuged at l000xg for 5 mm
at 4°C. Cell pellets were washed in 50 ml of ice-cold water. The pellets recovered by
centrifligation were resuspened in cracking buffer/inhibitor solution. The cracking
buffer (7.08 M urea, 4.4% w/v SDS, 35.4 mM Tris-HC1 pH 6.8, 0.09 mM EDTA, 0.35
mg/ml bromophenol blue, 0.88% v/v -mercaptoethanol) contained protease inhibitors
(0.006 mg/ml pepstatin A; Sigma, 0.002 mM leupeptin; Sigma, 9 mM benzamidine;
Sigma, 0.023 mg/ml aprotinin; Sigma, 0.05 mM PMSF; Boebringer Mannheim) and
was prepared immediately before needed and pre-warmed to 60°C. The ratio of 100 p1
of cracking buffer to 7.50D600units of cells was used. Total number of OD600 units was
equal to 0D600 of 1 ml sample x the culture volume. Proper amount of cracking buffer
was added to cell pellets. The cell suspension was then transferred to a crew-cap
microcentriftige tube containing 80 p1 of glass beads per 7.50D600units of cells. The36
sample was heated at 70°C for 10 mm and then vortexed for 1 mm. The supernatants
were collected by centrifugation at 14000 rpm for 5 mm in 4°C. The remaining pellet
debris was placed in a boiling water bath for 5 mm, vortexed for 1 mm and centrifuged
to collect the supernatants. Supernatants were combined and stored in -70°C freezer.
SDS-PAGE and Western blot
Proteins were subjected to 7.5-10% SDS-PAGE according to Laemmli (1970).
The gel was run at 120V until the bromophenol blue dye front reached the bottom of the
gel. After electrophoresis was completed, the gel was either stained with Coomassie
blue or transferred to the electroblotter apparatus (BioRad, Hercules, CA). The proteins
were electrotransferred to Optitran nitrocellulose membranes (Schleicher & Schuell,
Keene, NH) for overnight at 30V, followed by 2 hr at 60V. Non-specific sites on the
membrane were blocked with 5% nonfat dry milk and 1% BSA in TBST (20 mM Tris-
HC1 pH 7.6, 137 mM NaCl, 0.1% v/v Tween 20) for 1 hr. The membrane was then
incubated for 2 hr with monoclonal antibody against GAL4-DB (1:5000, Clontech) or
GAL4-AD (1:5000, Clontech). The bound antibody was detected by 1-hr incubation
with conjugated secondary antibody. Detection of bands was carried-out with the ECL
immunoblotting detection system (ECL, Amersham Pharmacia, Piscataway, NJ).
Proteolysis of phosphorylase-a and creatine kinase
Twenty p.g rabbit muscle glycogen phosphorylase and creatine kinase (Sigma;
P-1261, C-3755) were incubated for 15-30 mm at 30°C in buffer A (50 mM Tris-HC137
pH 7.4, 0.2 mM EGTA, 0.5 mM Dithiothreitol) in the presence of 2 mM CaCl2 with or
without 0.5 units of m-calpain (Sigma; P-4533). The reaction was then stopped by the
addition of 10 mM EDTA (final concentation). After the reaction had stopped, the
reaction mixtures were subjected to SD S-PAGE and the gels were then stained with
Coomassie blue.38
RESULTS
The expression of CID in L8/CID cell lines used in the experiments is under-
control of the LacSwitch expression system. Therefore, CW over-expression is
achieved by addition of IPTG to culture media. IPTG inhibits Lac I binding to the Lac
promoter, and thereby allows CID to be expressed. The presence of IPTG does not
affect Lac I and m-calpain mRNA (Huang and Forsberg, 1998). In this cell line, CII)
fragments are expected to non-selectively inhibit both p.- and m-calpains in an
unregulated manner.
Earlier studies with L8 cells (Hong and Forsberg, 1994) have documented that
serum withdrawal caused an approximately 20% increase in total protein degradation.
Therefore, the accelerated proteolysis of L8 cultured muscle cells with the use of
various protease inhibitors provides a good system for studying the protein degradation
pathways responsible for protein breakdown and the loss of different muscle proteins.
The continuous turnover of cell protein is typically measured in cells using
isotopic amino acid tracers in "pulse-chase" experiments (Goldberg and St. John, 1976).
After a short labeling of proteins, the decay of radioactive polypeptides is followed over
time. To dilute the reincorporation of radioactive amino acids released by proteolysis,
cells are administered large amounts of non-radioactive amino acids, or protein
synthesis is blocked with antibiotic inhibitors (i.e. cyclohexamide).39
Effects of IPTG on Total Protein Degradation in L8-CID muscle cells
Total protein degradation was estimated by measuring free 3H-tyrosine released
into the media following serum deprivation. Because muscle can neither synthesize nor
degrade this amino acid, tyrosine release reflects the breakdown of proteins (Taillandier
et al., 1996). Rates of total protein degradation increased asymptotically during the first
30 hr after serum withdrawal (Figure 6). According to a preliminary study, IPTG at
varying doses (0, 5, 7, 10 and 15 mM) were added to differentiated L8/CJD cells. 1PTG
did not affect total protein degradation in both 6 and 12 hr following serum withdrawal
(Figures 7 and 8). IPTG caused an approximate 20% reduction in degradation when 5-7
mM IPTG were added for 24 hr (Figure 9). However, those effects were not statistically
significant(Scheffetest). Concentrations above 7 mM were toxic and caused cells to
detach and die. Small inhibitory effects of CID expression on total protein degradation
were unexpected since it was reported to reduce total protein degradation by
approximately 60% when cells were exposed to IPTG for 24 hr (Huang and Forsberg,
1998). We also detected a similar degree of inhibition by 1PTG in three other L8/CID
clones where we varied the cell-differentiated period prior to administration of
treatments (i.e. treatments were started at days 6, 8, or 10 after differentiation was
induced; data not shown). Therefore, different clones and stages of differentiation did
not contribute to the low effect of CD expression in this study. However, it appears,
expression of CID did affect other aspects of muscle cell biology. Specifically, the m-
calpain concentration assessed by Western blot (Figure 10) was upregulated by CII)
expression.ru
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Figure 6. Time-dependent response of total protein degradation following serum
withdrawal inL8/CIDmyotubes. 3H-tyrosine-prelabeledL8/CIDmyotubes were
incubated for different times (0, 6,12, 18, 24and 30 hr) in DMEM as described in text.
After incubations, 1.5 mL-cultured media were collected and radioactivity was
determined.750
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Figure 7. Effect of [PTG on total protein degradationat 6 hours following serum
deprivation in L8/CID myotubes. 3H-tyrosine-prelabeled L8ICID myotubeswere
incubated with different 1PTG concentrations (0, 5, 7, 10 mM) in DMEM for 6 hoursas
described in text. After treatments, 1.5 mL-cultured mediawere collected and
radioactivity was determined. Overall protein degradation of IPTG-treated cells did not
differ significantly from control (0 mM IPTG). Resultsrepresent the mean of two
repeated experiments. Triplicates were done in each experiment..ss
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Figure 8. Effect of 1PTG on total protein degradation at 12 hours followingserum
deprivation in L8/CJD myotubes. 3H-tyrosine-prelabeled L8/CJD myotubeswere
incubated with different IPTG concentrations (0, 5, 7, 10, 15 mM) in DMIEM for 12
hours as described in text. After treatments, 1.5 mL-cultured mediawere collected and
radioactivity was determined. Overall protein degradation of IPTG-treated cells did not
differ significantly from control (0 mM IPTG). IPTG concentrations above 7 mMwere
toxic to the cells. Results represent themean of three repeated experiments. Triplicates
were done in each experiment.43
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Figure 9. Effect of IPTG on total protein degradation at 24 hours followingserum
deprivation in L8/CID myotubes. 3H-tyrosine-prelabeled L8ICJD myotubeswere
incubated with different IPTG concentrations (0, 5, 7, 10, 15 mM) in DMIEM for 24
hours as described in text. After treatments, 1.5 mL-cultured mediawere collected and
radioactivity was determined. Overall protein degradation of IPTG-treated cells did not
differ significantly from control (0 mM [PTG). At concentration 7 mM and higher,
IPTG was toxic to the cells. Results represent themean of three repeated experiments.
Triplicates were done in each experiment.44
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Figure 10. Effect of over-expressed CD, proteasome and lysosomal inhibitorson m-
calpain concentration in L8/CID myotubes. L8/CID cell lineswere treated with 1PTG,
ZLLL and methylamine for 48 hr. Forty p.g of each cultured cell lysate proteinwas
assessed by western blot. Polyclonal rat m-calpain antibodywas used to probe the blot
as described in the text. Numbers on top of the blot indicate percentage difference of
each band's intensity compared to control (no inhibitor).45
Effects of Methylamine on Total Protein Degradation
Methylamine is an agent that inhibits lysosomal enzymes by altering the pH of
the lysosome. Methylamine was reported to cause major increases in lysosomal pH by
0.52.0 pH units. In addition, it causes changes in lysosome morphology (Myers et al.,
1995). We evaluated effects of methylamine on protein degradation in cultured muscle
cells in order to determine the contribution of the lysosome to total protein degradation
(Figures 11 and 12). Methylamine significantly reduced total protein degradation in
both 12 and 24 hr following serum withdrawal (p<O.000l). Ten-mM methylamine
caused a 40% reduction in degradation. Concentrations above this were toxic to the
muscle cells.
Effects of ZLLL on Total Protein Degradation
To evaluate the role that the proteasome plays in turnover of proteins in cultured
muscle cells, we examined effects of proteasome inhibitors on release of radioactivity
from pre-labelled myotubes. ZLLL or MG-132, a synthetic membrane-permeable
proteasome inhibitor, effectively blocked ATP-dependent protease activity in CHO cell
lines (Jensen et al., 1995; Nawaz et al., 1999). The effect of ZLLL was tested in the
dose range of 30 to 100 nM. We found that ZLLL could significantly reduce total
protein degradation in L8/CID cells at both 12 and 24 hr (p<0.0001). ZLLL caused a
progressive reduction in total protein degradation and, at 30 and 5OnM, inhibited total
protein degradation by approximately 50 and 62%, respectively (Figures 13 and 14).
Concentrations above this were toxic. At 30 nM, the effect of ZLLL on proteolysis1500
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Figure 11. Effect of methylamine on total protein degradationat 12 hours following
serum deprivation in L8IC1D myotubes. 3H-tyrosine-prelabeled L8/C1D myotubes were
incubated with different methylamine concentrations (0, 8, 10, 15 mM) in DMEM for
12 hours as described in text. After treatments, 1.5 mL-cultured mediawere collected
and radioactivity was determined." * " indicates thistreatment differed significantly
(p<0.0001) from control (0 mM methylamine). Methylamineat 15 mM was toxic to the
cells. Results represent the mean of two repeated experiments. Triplicateswere done in
each experiment.3000
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Figure 12. Effect of methylamine on total protein degradation at 24 hours following
serum deprivation in L8/CID myotubes. 3H-tyrosine-prelabeled L8/CIID myotubes were
incubated with different methylamine concentrations (0, 8, 10, 15 mM) in DMEM for
24 hours as described in text. After treatments, 1.5 mL-cultured mediawere collected
and radioactivity was determined." *" indicates this treatment differed significantly
(p<0.0001) from control (0 mM methylamine). Methylamine at 15 mMwas toxic to the
cells. Results represent the mean of two repeated experiments. Triplicateswere done in
each experiment.iPAiIs:
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Figure 13. Effect of ZLLL on total protein degradation at 12 hours following serum
deprivation in L8/CID myotubes. 3H-tyrosine-prelabeled L8/CID myotubeswere
incubated with different ZLLL concentrations (0, 30, 50, 100 nM) in DMEM for 12
hours as described in text. After treatments, 1.5 mL-cultured media were collected and
radioactivity was determined." * "indicates this treatment differed significantly
(p<O.0001) from control (0 nM ZLLL). ZLLL at 100 nM was toxic to the cells. Results
represent the mean of two repeated experiments. Triplicates were done in each
experiment.2000.
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Figure 14. Effect of ZLLL on total protein degradation at 24 hours following serum
deprivation in L8/CID myotubes. 3H-tyrosine-prelabeled L8/C1D myotubeswere
incubated with different ZLLL concentrations (0, 30, 50, 100 nM) in DMEM for 24
hours as described in text. After treatments, 1.5 mL-cultured mediawere collected and
radioactivity was determined." * "indicates this treatment differed significantly
(p<0.0001) from control (0 nM ZLLL). ZLLL at 100 nM was toxic to the cells. Results
represent the mean of two repeated experiments. Triplicates were done in each
experiment.50
was greater than that effect of 10 mM methylamine. These data demonstrate that a large
portion of muscle protein degradation is mediated by lysosomal proteases and the
proteasome.
Coordination of the Protease System to Total Protein Degradation
To study the effects of the combination of proteases on protein breakdown, we
examined 24-hr total protein degradation with a 3H-tyrosine labeling experiment.
Inhibitors tested included 30 nM ZLLL, 10 mM methylamine and 5 mM IPTG. These
concentrations were selected based on their inhibitory responses (i.e. not too high to be
able to observe the additive effects and were not toxic to the cells). As seen in previous
experiments, 1PTG caused only a slight reduction in degradation. ZLLL and
methylamine either alone or in combination with others significantly inhibited total
protein degradation (Figure 15). However, the presence of JPTG with either
methylamine or ZLLL did not show greater reduction in protein degradation. The
combination of ZLLL and methylamine or three inhibitors together had the highest
inhibitory effect (67%). Cell toxicity was observed in the treatments with all inhibitors
and IPTG plus methylamine.
Evaluation of the effects of the inhibitors on stability of the myofibrillar and
non-myofibrillar protein pools was achieved by measuring 3H-tyrosine remaining in
these protein fractions following incubation in the presence of inhibitor or 1PTG. The
reduction of the myofibrillar and non-myofibrillar protein pool during 24 hr of serum
withdrawal was approximately 31% and 38%, respectively. The intracellular pools did51
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Figure 15. Effects of 24 hr-treatment of various protease inhibitors on total protein
degradation following serum withdrawal in L8/CJD cell lines. 3H-tyrosine-prelabeled
L8/CID myotubes were incubated with different inhibitor concentrations (5 mM IPTG,
30 nM ZLLL and 10 mM methylamine in DMEM for 24 hours as described in text.
After treatments, 1.5 mL-cultured media were collected and radioactivity was
determined. " * " indicates this treatment differed significantly(Scheffetest) from
control (no inhibitor). Results represent the mean of three repeated experiments.
Triplicates were done in each experiment.52
not change significantly following incubation with inhibitors(Scheffetest). We found
that methylamine had the greatest effects (+27%) on stabilizing both intracellular pools
(Figures 16 and 17). IPTG increased the myofibrillar pool by 4%. ZLLL had slight
effects on myofibrillar protein pool size (+10%). IPTG increased the effect of ZLLLon
non-myofibrillar pooi from 5 to 12% and myofibrillar pool from 10 to 14.5%. These
data indicate that the lysosome and proteasome contribute to degradation of total
proteins in muscle cells. The net contribution of the proteasome is slightly higher than
that of lysosome. Lysosomal function seems essential for the enhanced proteolysis of
both protein pools. The ubiquitin-proteasome pathway hasa greater effect on the
myofibrillar compartment than the non-myofibrillar compartment. The role of calpain in
regulation of myofibrillar and non-myofibrillar protein pool size is inconclusiveas it
had only a slight inhibitory effect on total protein degradation in L8/CID cells.
Stabilization of Muscle Proteins by the Protease Inhibitors
In order to determine whether the various protease systems cooperatively
degrade cytoskeletal/myofibrillar proteins, we assessed the degradation of desmin,a-
actinin, filamin, tropomyosin and dystrophin in L8/CID cell lines. Differentiated
L8/CID cell lines were divided into five groups. The firstgroup was a control group (no
treatment). The others were treated with IPTG or methylamine+IPTG, ZLLL+IPTG and
ZLLL+methylamine for 48 hr. Serum withdrawal was applied at day 2. At the end of
treatment, proteins were extracted and subjected to SDS-PAGE. Western blottingwas
performed. Lac I concentration was determined asan internal control for equal loading25
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Figure 16. Effects of 24 hr-treatment of various protease inhibitors on stability of non-
myofibrillar proteins in L8/CID cell lines. 3H-tyrosine-prelabeled L8ICJD myotubes
were incubated with different inhibitor concentrations (5 mM IPTG, 30 nM ZLLL and
10 mM methylamine in DMEM for 24 hours as described in text. After treatments, the
non-myofibrillar proteins were collected and radioactivity was determined. The non-
myofibrillar protein pools of inhibitor-treated cells did not differ significantly from
untreated cells at 24 hr following serum withdrawal. " * "indicates statistically
significant reduction of non-myofibrillar proteins (no inhibitor) at 24 hr over 0 hr.
Results represent the mean of three repeated experiments. Triplicates were done in each
experiment.II
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Figure 17. Effects of24hr-treatment of various protease inhibitors on stability of
myofibrillar proteins inL8/CIDcell lines. 3H-tyrosine-prelabeledL8ICIDmyotubes
were incubated with different inhibitor concentrations(5mMIPTG, 30 nM ZLLLand
10 niM methylamine inDMEMfor24hours as described in text. After treatments, the
myofibrillar proteins were collected and radioactivitywas determined. The myofibrillar
protein pools of inhibitor-treated cells did not differ significantly from untreated cellsat
24hr following serum withdrawal." * " indicates statistically significant reduction of
myofibrillar proteins (no inhibitor) at24hr over 0 hr. Results represent the mean of
three repeated experiments. Triplicates were done in each experiment.55
(Figure 18). The experiment was repeated twice. The Western blot results showed that
inhibition of all proteolytic pathways in muscle cells stabilized m-calpain. The greatest
effects were seen in IPTG-treated cells (+60%, Figure 10). After autolytic activation
that generates 78-and 28-kDa m-calpain and 76- and 1 8-kDa polypeptides of j.t-calpain,
calpain eventually autolyzes to produce 35-, 22-, and 18-kDa fragments for m-calpain
and the 55-, 34- and 21-kDa fragments for .t-calpain (Nishimura and Goll, 1991).
Calpastatin is a calpain specific inhibitor that binds to and inhibits calpain activity by
preventing calpain autolysis (Saido et al., 1994; Goll Ct al., 1989), thus inhibiting
calpain degradation. These results indicate that the lysosomal and proteasome pathways
may be responsible for the ftirther degradation of autolyzed calpain in muscle cells.
Western blotting revealed the additive effect on accumulation of desmin (Figure
19: panel A) in 1PTG plus ZLLL- or methylamine-treated cells (+181% and +284%,
respectively). It seems likely that the effect of methylamine on stabilization of desmin
was slightly higher than that of ZLLL. Dystrophin was stabilized by IPTG, ZLLL and
methylamine (Figure 19: panel B). Combination of 1PTG and either ZLLL or
methylamine increased dystrophin concentration (+353% and +376%, respectively).
The accumulation of cx-actinin and filamin was clearly detected only following
treatment with ZLLL plus methylamine (+62% and +11%; Figures 20: panel A and B,
respectively). Even though filamin is known to be a substrate of calpain,no difference
was observed following the addition of IPTG. Tropomyosin levels were increased in all
treatments compared to control (Figure 21). Taken together, results from the inhibitor
treatments and Western blot analysis of L8/CID cells indicated the coordination of the56
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Figure 18. Effect of over-expressed CD, proteasome and lysosomal inhibitorson Lad
concentration in L8/CID myotubes. L8/CID cell lineswere treated with IPTG, ZLLL
and methylamine for 48 hr. Forty tg of each cultured cell lysate proteinwas assessed by
western blot. Polyclonal Lad antibody was used to probe the blot as described in the
text. Numbers on top of the blot indicate percentage difference of each band's intensity
compared to control (no I).A: Desmm
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Figure 19. Effect of over-expressed CD, proteasome and lysosomal inhibitors on
desmin (panel A) and dystrophin (panel B) concentration in L8/CID myotubes. L8/CID
cell lines were treated with IPTG, ZLLL and methylamine for 48 hr. Sixtyp.g of each
cultured cell lysate protein was assessed by western blot. Monoclonal desmin and
dystrophin antibodies were used to probe the blots as described in the text. Numberson
top of the blots indicate percentage difference of each band's intensity compared to
control (no inhibitor). Numbers belowed the blots indicate the inhibitor treatments. 1:
no inhibitor; 2: IPTG; 3: IPTG plus ZLLL; 4: IPTG plus methylamine; 5: ZLLL plus
methylamine.58
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Figure 20. Effect of over-expressed CID, proteasome and lysosomal inhibitors on a-
actinin (panel A) and filamin (panel B) concentration in L8/CID myotubes. L8ICID cell
lines were treated with IPTG, ZLLL and methylamine for 48 hr. Forty p.g of each
cultured cell lysate protein was assessed by western blot. Monoclonal ct-actinin and
filamin antibodies were used to probe the blots as described in the text. Numbers on top
of the blots indicate percentage difference of each band's intensity compared to control
(no inhibitor). Numbers belowed the blots indicate the inhibitor treatments. 1: no
inhibitor; 2: IPTG; 3: IPTG plus ZLLL; 4: IIPTG plus methylamine; 5: ZLLL plus
methylamine.59
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Figure 21. Effect of over-expressed CD, proteasome and lysosomal inhibitorson
tropomyosin concentration in L8/CID myotubes. L8/CID cell lines were treated with
1PTG, ZLLL and methylamine for 48 hr. Forty j.tg of each cultured cell lysate protein
was assessed by western blot. Monoclonal tropomyosin antibody was used to probe the
blot as described in the text. Numbers on top of the blot indicate percentage difference
of each band's intensity compared to control (no I).protease systems in degradation of a variety of muscle proteins. Calpain plays a role in
initiating protein degradation of a number of proteins especially desmin and dystrophin.
Proteasome and lyso some contribute to degradation of individual proteins into amino
acids, particularly desmin, tropomyosin and dystrophin, and are mainly responsible for
a-actinin and filamin degradation.
Screening of the Human Skeletal Muscle cDNA Library with m-Calpain cDNA
To screen for proteins able to interact with m-calpain, we used the yeast
expression system designed to detect protein-protein interactions as a result of their
ability to reconstitute the transactivation function of the GAL4 protein. Thus, dominant
negative-80K- and 78A4-mCL cDNA (mCL: m-calpain large subunit) were inserted
into pAS2-1, fused in-frame to GAL4-BD (see Figure 4). Expression of GAL4-
BD/calpain proteins was confirmed by Western blot using antibodies against GAL4-BD
(Figure 22). Co-expression of 80K or 78A4 with pACT2 (a vector that encodes DNA
sequences corresponding to the GAL4-AD) in the yeast Y190 containing a GAL4
binding site that drives expression of lacZ did not provide any activation of lacZ
expression. Fusion of human skeletal muscle cDNA library to the GAL4-AD in
pGAD 10 led to the appearance of four colonies strongly expressing lacZ (Table 2)
when transformed into the yeast pre-transformed with 80K or 78A4 containing
plasmids. Transformation efficiency was 1-2x iø colony-forming unit (cth)/jtg DNA
and approximately3-4x106clones were screened. We detected no positive clones from
the library screen using other forms of m-calpain (78K, 80M), native m- and p.-calpain61
80K 78A4 p53
Figure 22. Expression of m-calpain/GAL4-BD hybrid proteins in theyeast strain Y 190.
Yeast cell lysates were prepared as described in text from yeast cells expressing
mCLDN, 78A4 and p53 (positive control). Sixty p.1 of each lysatewas subjected to
SDS-PAGE (10%). The membrane was probed with monoclonal antibodies for GAL4-
BD.62
Table 2. Interaction between calpain and proteins in skeletal muscle cDNA library
In pAS2-1 In pGAD1O 3-galactosidase
activity (unit)
Growth on SD/-
leu,-trp,-his,+3AT
p53 SV4OlargeT
antigen
179.1±15.85 +
80K - 0.22±0.12
80K Ca2-ATPase 25.39±3.35 +
80K Glycogen
phosphorylase
9.34±0.89 +
78A4 Nebulin-related
protein
22.53±8.59 +
78A4 Creatine idnase 5.25±0.17 +
78M 0.02±8.86 -63
as the baits. Very small background (<5%) could be detected from the p-calpain screen
after 14-day incubation suggesting the toxicity effect of overexpressed p.-calpain.
Verification of Positive Two-Hybrid Interaction
After recovering the plasmids encoding cDNAs which interacted with calpain
cDNA, the cDNA plasmids were re-transformed with the bait plasmids into the yeast
strain Yl 87 to reconstitue the GAL4-driven expression of lacZ. Unfortunately, we
could not detect lacZ expression in any clones. In order to confirm the interaction of
fusion proteins by another method, the yeast mating experiments were performed as
mentioned previously (Table 1) with and withoutCa2ionophore A 23187 (Sigma) in
the media (1 mM final concentration). Again, we could not detect any clones expressing
lacZ. We amplified the cDNA inserts by PCR using primers specific to GAL4-AD and
pGAD1O. The PCR products revealed the nucleotide fragments of approximately 3.9,
2.0, 3.1 and 2.3 kb generated from four different clones (Figure 23). Sequencing results
of these cDNAs identified the encoding proteins to be Ca2-ATPase, novel nebulin-
related protein, creatine kinase and glycogen phosphorylase, respectively. The Genbank
entry numbers are gbfU96773, gb1U76618, gbIMl47SO and gbfM32579-M32598,
respectively. From the sequencing profiles, we discovered that all cDNA inserts were
not subcloned in-frame to the GAL4-AD. Therefore, the presence of internal stop codon
derived from the shift of reading frame causes the early termination of expressed-
GAL4-AD/cDNA fusion proteins at nucleotides 79, 19, 67 and 301 downstream of the
fusion point (Figure 24). These results indicate that incomplete expression of the fusing64
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Figure 23. PCR-amplified products of the human skeletal muscle eDNA library
plasmids derived from two-hybrid screening with m-calpain. These eDNAs encode
Ca2tATPase (Lane 1), nebulin-related protein(Lane 2), creatine kinase (Lane 3) and
glycogen phosphorylase (Lane 4). Lane M is a 0.5 kb DNA ladder.GAL4-AD 1 2 3 4
Figure 24. Expression of library/GAL4-AD hybrid proteins in the yeast strain Y 190.
Yeast cell lysates were prepared as described in text from yeast cells expressing GAL4-
AD only (positive control), Ca2tATPase (Lane 1), nebulin-related protein (Lane 2),
creatine kinase (Lane 3) and glycogen phosphorylase (Lane 4). Sixty t1 of each lysate
was subjected to SDS-PAGE (10%). The membrane was probed with monoclonal Ab
for GAL4-AD.cDNAs may be due to confirmation failure or the presence of another factor(s) needed
endogenously to mediate the binding of the fusion proteins.
Substrate Cleavage by m-Calpain
To investigate whether the two-hybrid candidates could be cleaved by calpain, the
in vitrohydrolysis of glycogen phosphorylase and creatine kinase by m-calpain was
evaluated. Figure 25 shows the SDS-PAGE pattern of hydrolytic products of creatine
kinase after 15 mm-incubation with calpain in the presence of Ca2. We also found that
calpain cleaved glycogen phosphorylase into five smaller fragments (Figure 26).
Prolonged incubation for 30 mm resulted in the increase in the breakdown products. No
proteolysis of substrates was observed in the absence of calpain. These results
suggested that creatine kinase and glycogen phosphorylase arein vitrosubstrates of m-
calpain. We have not yet investigated the two other two-hybrid candidates(Ca2-
ATPase and nebulin-related protein) since we could not find the commercially available
sources of these purified proteins.1 2 3M
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Figure 25. SDS-PAGE (10%) showing the effects of digestion by m-calpainon creatine
kinase. Creatine kinase (20 ng) was incubated at 30°C for 15 mm in buffer A in the
presence of 2 mM CaC12, without calpain (lane 1) and with calpain (lane 2). Lane 3
shows the reaction mixture with no creatine kinase. Thearrows indicate the degraded
fragments.-mCL15mm 30mm
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Figure 26. SDS-PAGE(7.5%)showing the effects of digestion by m-calpain on
glycogen phosphorylase. Glycogen phosphorylasewas incubated at 30°C for the time
indicated with0.5unit m-calpain in buffer A in the presence of 2 mM CaC12. The
reaction was stopped by addition ofexcess EDTA. The arrows indicate the degraded
fragments.DISCUSSION
Individual proteins are degraded at widely different rates. For example, while
some regulatory proteins have a half-life as short as 15 minute, permitting adaptation to
new physiological conditions and changes in cell composition, actin and myosin in
skeletal muscle are turning over only once every one to two weeks (Lecker et al., 1999).
In conditions such as fasting, metabolic acidosis, muscle denervation, sepsis and
cachexia, an increase in proteolysis corresponds to an increase in the protease activities
(Furono et al., 1990; Hummel Ct al., 1998). This response can be blocked with inhibitors
of the protease systems (Furono et aL, 1990
The present study tested the role of different proteolytic pathways in
accelerated-induced muscle proteolysis. There is strong evidence that the induction of
the proteolytic pathways contributes to the rapid loss of the contractile proteins
observed in several pathological conditions (Tidball 1995; Medina et al., 1991; Wing et
al., 1995). Since the protein content of any cell depends on the balance between rates of
protein synthesis and degradation, a rise in proteolysis can by itself induce muscle
wasting. Our studies suggest that increased Ub-proteasome pathway mainly contributes
to the accelerated muscle proteolysis. Lysosomal protease pathway also plays an
important role. Clearly, the calpains are not essential to the rise in overall proteolysis
(Figure 15). However, it is probably misleading to underestimate the involvement of the
calpain system in muscle protein degradation based on the inhibition effect of the CD
overexpression. Since the CD expressed in L8/CID cell lines contains only the70
polypeptide fragments adopted from a consensus motif of highly conserved amino acid
sequences presented in subdomain B of calpastatin inhibitory domain (see Figure 2).
Analysis of various mutants and fragments of calpastatin inhibitory domain (Ma et al.,
1994) had shown that all three subdomains correlate with potentiation of calpain
inhibition. They also found that deletion of subdomains A and B diminishes the calpain-
inhibition activity by 50% and completely abolishes calmodulin-like domain binding
acitivity of calpastatin. Therefore, the CD expressed from L8/CID cell lines may not
process fl.ill activity as the whole CD proteins and this may result in the low inhibitory
effect observed in our experiments.
The regulatory role of calpastatin on calpain has been studied extensivelyin
vitro (for review see Maki et al., 1990). The biological importance of the
calpain/calpastatin ratio in cells was demonstrated in myoblast fttsion (Barnoy et al.,
1996). Our studies suggest that calpastatin regulates calpain level and activityin vivo.
This finding supports the model for regulation of calpain activity, in which elevated
calpastatin levels inhibit an unaltered level of calpain protease (Potter et al., 1998).
Calpain subunits are reported to dissociate in the presence of calcium ion (Anagli et al.,
1996; Michetti et al., 1997). Calpastatin may keep the two subunits together and
stabilize the calpain molecule where the monomeric form is more calcium sensitive but
unstable. Autolyzed calpains were reported to disappear very rapidly after activation
(Nishimura and Goll, 1991). Our observations that proteasome and lysosome inhibitors
stabilize m-calpain indicate that both protease systems are involved in calpain turnover.71
In our studies, we found that lysosome can account for large and equal portions
of myofibrillar and non-myofibrillar protein breakdown in L8/CJD muscle cells. This
observation is contrary to a previous report by Lowell et al. (1986) in which evidence
was found that lysosomes are not involved in the degradation of myofibrillarprotein in
rat skeletal muscle. Instead, the Ub-proteasome pathway was mainly responsible for the
myofibrillar pool breakdown (Lecker et aL, 1999). The factor that may contribute to this
contradiction is the cell differentiation rate. The L8/CID myotube half-life is
approximately 2-4 days depending on the myoblast confluency at which it was induced
to differentiate. Our treatments were completed at day 8 in which some cells (-2O%)
were shown to detach from the culture plates. Hence, the condition such as cell
senescence which is not critical in intact muscle experiments, may be a major
interfering factor given that lysosomal pathway is responsible for the turnover of protein
in this condition. In addition, our results also indicate that the lysosome contributes non-
specifically to overall increased muscle proteolysis which happened during accelerated
protein degradation. The findings that calpain increases the effect of myofibrillar
protein degradation by the proteasome support the calpain role on limited proteolysis
and the role of proteasome on degradation of myofibrillar proteins.
Several lines of evidence suggest that calpain may be the rate-limiting protease
in muscle protein degradation. Calpain has limited and specific effects on muscle
proteins. Calpains cleave a limited number of proteins and cleave these proteins at a
limited number of sites, leaving large polypeptide fragments to be degraded by the other
protease systems (Goll et al., 1992a). Calpain initiates the release of thick and thin72
filaments from the surface of myofibrils (Go!! et al., 1992a) and also rapidly degrades
proteins in costameres (Taylor et al., 1995) which results in separation of the
sarcolemma from the myofibril (Figure 27). Desmin, filamin, tropomyosin and
dystrophin are reported to be degraded by calpain (O'Shea et al., 1979; Davies et al.,
1978; Goll et al., 1999; Yoshida et al., 1992). Vety little degradation of undenatured a-
actinin was observed after prolonged exposure to calpain (Thomson et aL, 1993).
Our results that tropomyosin, desmin and dystrophin were stabilized by
inhibition of calpain activity indicate that calpain plays a regulatory role in the turnover
of these proteins. More importantly, the effects of proteasome and lysosomal inhibitors
are additive to the effects of calpain inhibition on desmin and dystrophin stabilization.
These findings support the role of calpain in the rate-limiting step in myofibrillar and
cytoskeletal protein degradation.
We used the two-hybrid system to search for calpain-binding proteins. The yeast
GAL4-based system has both advantages and disadvantages. The GAL4 DNA-binding
domain is believed to be more efficiently localized to the nucleus (for review see Bartal
et al., 1993). The experiments must be performed in gal4 yeast strains to avoid
background due to activation of the reporter system by endogenous GAL4. The basal
expression of HIS3 can be easily suppressed by 3AT, a chemical inhibitor of the yeast
histidine biosynthetic pathway. In the two-hybrid system, the interactions are detected
within the natural environment of the cell. However, the use of protein fusion also
means that the protein of interest may not fold exactly as the original unfused protein
and the site of interaction maybe occluded by one of the transcription factor domains.73
Costameres
(ankyrin, desmin,
dystrophin, frspecfrmn, Tronemembrane plaques
y-actin, latin, vinculin) (integrins, DAGs, DAPs)
Figure 27. Schematic diagram showing the structure and protein composition of
costameres in striated muscle relative to Z-disks and the myofibrillar lattice. The
position of titin is shown in this diagram, but nebulin filaments have been omitted to
simplify the diagram. The N-tenninal end of the large titin molecule is anchored in the
Z-disk. Desmin, vinculin and ankylin, three of the protein constituents of costameres,
extend into the muscle cell where they encircle myofibrils at the Z-disk and run from
myofibril to myofibril to link adjacent Z-disks laterally (Taylor et al., 1995). DAPs =
dystrophin-associated proteins; DAG = dystrophin-associated glycans; S = skelemins.74
Since false-positive clones caused by non-specific binding is known to be a
major problem in yeast cDNA library screening (Luo et al., 1996), it was surprising that
we could only detect total of 18 clones that expressed 3-galactosidase by repeatedly
screening library with different baits. Only 4 out 18 plasmids encoded the known
proteins. The remaining were considered to be false positives since they either
expressed reporter gene without DNA-BD/calpain fusing proteins or encoding very
short sequences with no identity.
Two major points need to be addressed for they may affect the in vivo binding of
calpain with its interacting partner in the two-hybrid system. First, tissue-purified
calpain is phosphorylated. McClelland et al. (1994) reported that m-calpain is
phosphorylated by Ca2/calmodulin-dependent protein kinase only after autolysis
indicating that phosphorylation may be necessary for calpain activity. Calpain can be
phosphorylated by several protein kinases (Kuo et al., 1993). Hence, interactions
dependent on a post-translational modification that does not occur in yeast cells will not
be detected. For example, phosphorylation on a tyrosine residue may not occur in yeast
(Fields and Sternglanz, 1994). Second, calpastatin binds calpain in a Ca2-dependent
manner. We found that calpastatin did not bind calpain in the yeast two-hybrid system.
Calpastatin binds calpain near a catalytic center and mutation of the active site
residue of calpain does not interfere calpastatin-binding activity (Crawford et al., 1993).
These studies suggestCa2concentration is rather low in yeast (Sorimachi et al., 1995)
and Ca2-dependent binding of m-calpain may not occur in the yeast cell.75
We considered four proteins (Ca2tATPase, nebulin-related protein, creatine
kinase (CK) and glycogen phosphorylase) resulting from screening the skeletal muscle
cDNA library as potential candidates forin vivosubstrates of m-calpain. In the cell, CK
is bound to intracellular compartments, and is functionally coupled to enzymes and
transport systems involved in energy production and utilization (Ventura-Clapier et al.,
1998) whereas glycogen phosphorylase is an enzyme involved in glycogenolysis. We
have shown that creatine kinase and glycogen phosphorylase arein vitrosubstrates of
calpain. This finding suggests that creatine kinase and glycogen phosphorylase interact
with m-calpain. m-Calpain may regulate the degradation of creatine kinase and
glycogen phosphorylase and possibly regulate their activities.
Nebulin-related protein (N-RAP), a 1 33-kDa protein, is specifically expressed in
skeletal and cardiac muscle. N-RAP is part of a complex of proteins that anchors the
terminal actin filaments of the myofibril to the membrane, and functions in transmitting
tension from the myofibrils to the extracellular matrix (Figure 28; Luo et al., 1999).
There is evidence showing that N-RAP shares extensive similarity with the C-terminal
region of human nebulin (Luo et al., 1997). Nebulin is an excellent substrate for the
calpain. Calpain rapidly degrades nebulin to a series of smaller fragments which
evidently remain bound to actin (Taylor et al., 1995). Based on the structural similarity
between nebulin and N-RAP, N-RAP could possibly be cleaved by calpain.
Two studies showed the plasma membrane calcium pump (Ca2-ATPase) is a
preferred t-calpain substrate within the erythrocyte (Salamino et al., 1994; Molinari et
al., 1994). Ca2-ATPase is stimulated by interaction with calmodulin at the site close toNH2
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Figure 28. Possible schematic diagram for linking the terminal actin filaments of
myofibrils to the cell membrane. The domain organization of N-RAP is shown at the
top, with distinct hatch patterns marking the positions of the nebulin-related region and
the LIM domain. These domains are shown binding to the terminal actin filaments and
to talin, respectively; talin in turn binds to the 31D integrin subunit, completing the
linkage between the myofibril and the plasma membrane (numeral 1). Interactions
between talin and actin filament (numeral 2) and between vinculin and talin, actin and
N-RAP (numeral 3) are sequentially added. The integrins transmit tension produced by
cytoplasmic structures to the extracellular matrix (ECM, Luo et al., 1999).77
its C-terminus. In the absence of calmodulin, calpain cleaves the purified Ca2-ATPase
at the calmodulin-binding domain resulting in an active 124 kDa-polypeptide (James et
al., 1989). However, in thein vivoenvironment, the end result of calpain action is the
complete inactivation of the pump. These observations suggest that m-calpain, a closely
related isoform of -calpain may also interact with Ca2tATPase and may regulate
Ca2-ATPase activity and degradationin vivo.
Since p.-calpain and m-calpain have very similar if not identical subsite
specificities, they may degrade the same protein substrates inin vitroassays (Goll et al.,
1999). For example, calpain prefers Val or Leu in the P2 position and less stringent at
the P1 position (Sasaki et al., 1984). The presence of the secondary recognition
sequence(s) adjacent to the cleavage sites dictates substrate's susceptibility to calpain
(Wang et al., 1989; Molinali et al., 1995). Consequently, it is reasonable to assume that
p.- and m-calpain are capable of cleaving the same substrates in living cells.
Additional studies are needed to learn whether m-calpain associates with and/or
cleaves these proteinsin vivo.The incomplete expression of candidate cDNAs retrieved
from the two-hybrid clones can be overcome by correcting the reading-frames or
replacing the screened-cDNA with the full-length cDNA sequences of the human Ca2t
ATPase, nebulin-related protein, creatine kinase and glycogen phosphorylase genes (if
available). The actual protein-protein interaction should be verified by performing the
yeast two-hybrid system. Alternatively, the interactions of the protein hybrids can be
confirmed by immunoprecipitation, ELISA using antibodies against the yeast GAL4,
calpain or proteins of interest and by affinity column chromatography. If an interaction78
is detected, deletions can be made in the DNA encoding either calpain or its partner to
identify a minimal domain for interaction. In addition, point mutations can be assayed
to identify specific amino acid residues critical for the interaction. The findings may
provide the role of calpain in regulation of protein degradation and function of calpain
in the cell.79
CONCLUSION
Serum withdrawal increased myofibrillar and non-myofibrillar protein
degradation in L8/CID muscle cells by 31 and 38%, respectively. The inhibition of
cellular protease systems reduced total protein degradation by approximately 67%. The
protease systems including the lysosomal, Ub-proteasome and calpain systems which
coordinately regulated intracellular proteolysis. Ub-proteasome and lysosomal pathways
account for most protein degradation. Lysosomes contributed non-selectively to cellular
protein turnover. The Ub-proteasome system appears mainly responsible for the
myofibrillar pool degradation. Calpain plays definite roles in protein degradation in
muscle cells. Calpain is important for initiating degradation of myofibrillar, cytoskeletal
proteins and a number of individual proteins especially desmin and dystrophin.
Inhibition of calpain stabilized tropomyosin, desmin and dystrophin. Inhibition of
proteasome and lysosome also stabilized tropomyosin, desmin and dystrophin as well
and stabilized other proteins such as a-actinin and filamin indicating the involvement of
the Ub-proteasome and lysosomal pathways in the turnover of these proteins.
By screening skeletal muscle cDNA library using the yeast two-hybrid system,
four partial cDNAs which encoded creatine kinase, glycogen phosphorylase,Ca2-
ATPase and nebulin-related protein were identified as potential candidates of m-
calpain-binding proteins. Purified creatine kinase and glycogen phosphorylase were
cleaved by m-calpain in an in vitro assay. We have not yet evaluated whetherCa2-
ATPase and nebulin-like protein also serve as substrates for calpain.80
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